Implantable drug-eluting device (1) comprising a microporous structure (2) having regularly arranged pores (4, 5) in at least two different uniform sizes, and manufacturing method. The pores are configured for receiving a drug (9) and are being connected by interconnections (6, 7). Interconnections (6) originating from pores (4) of a first size have a first elution area and interconnections (7) originating from pores (5) of a second size have a second elution area. The interconnections convey the drug (9) to a surface of the device for elution to surrounding tissue. The ratio between the first and the second elution areas is predefined and selectable. The differently sized elution areas provide for different outflow rates. This allows for simple but reliable dispensing of drugs at positively controlled and well determined rates. Particularly, this enables a single implantable device to dispense drugs over preselectable durations of time, like short-term or long-term.

A method of forming a shoulder prosthesis includes resecting an end portion of a humerus to form a resected end of the humerus and a resected portion separated from the humerus, the resected portion having an outer convex surface and an inner surface. The inner surface of the resected portion is processed to include a concave articular surface. The outer convex surface of the resected portion is implanted in the resected end of the humerus. An implant having a convex articular surface is secured to a glenoid. The concave articular surface of the resected portion is articulated with the convex articular surface of the implant.

A system of prosthetic implants for a total knee replacement procedure is provided. The system includes a tibial component of a knee joint implant, a tibial insert configured to be positioned against the superior side of the platform of the tibial component, a first femoral component of a knee joint implant, and a second femoral component of a knee joint implant.

An implant for a human includes a body having a superior surface, an inferior surface, a distal surface, and a proximal surface. The proximal surface is configured to engage the talus and the calcaneus of an adult human, and the distal surface configured to engage at least the first and fourth metatarsals of the adult human. The distal surface has a largest distal height and a largest distal width that is greater than the largest distal height, and the proximal surface has a largest proximal height and a largest proximal width that is greater than the largest proximal height.

The invention relates to an implant (1) for the treatment of bone, in particular for covering defects or drill holes or for the reconstruction of bone defects or malformations. This comprises at least one frame structure (2) and at least one adaptation area (3). The edge of the implant (4) is thereby partially, but not continuously, formed by the frame structures (2), which are located outside the adaptation area (3).

The present invention relates to an implant (1) for the correction of gleno-humeral instability, in particular for the correction of a glenoid defect (Dg) of the glenoid (G) of a patient, said implant (1) having a substantially flat portion (3), said substantially flat portion (3) being suitable, when said implant (1) is in use, for being placed at the site of the glenoid defect (Dg) in contact with the external bone portion of the glenoid (G) of a patient, said implant (1) being characterized in that at least said flat portion (3) is made of heterologous deproteinized bone material.

In various embodiments, an implant for interfacing with a bone structure includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue. In some embodiments, a method is provided that includes accessing an intersomatic space and inserting an implant into the intersomatic space. The implant includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue.

There is disclosed a talus implant comprising a base having at least one hole and at least one pin. There is also a top comprising at least one hole and at least one pin, wherein the top is configured to be inserted into the base. At least one embodiment comprises a tibial implant comprising at least one post and at least one base coupled to the at least one post. Additionally, there is at least one pad coupled to the at least one base, wherein the at least one pad is selectively insertable into and removable from the at least one base. A method for fabricating a talus and tibial implant is disclosed and also a method for inserting a talus implant and a tibial implant into a patient having a damaged talus joint.

In various embodiments, an implant for interfacing with a bone structure includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue. In some embodiments, a method is provided that includes accessing an intersomatic space and inserting an implant into the intersomatic space. The implant includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue.

Bone implants, including methods of use and assembly. The bone implants, which are optionally composite implants, generally include a distal anchoring region and a growth region that is proximal to the distal anchoring region. The distal anchoring region can have one or more distal surface features that adapt the distal anchoring region for anchoring into iliac bone. The growth region can have one or more growth features that adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth. The implants may be positioned along a posterior sacral alar-iliac (“SAI”) trajectory. The implants may be coupled to one or more bone stabilizing constructs, such as rod elements thereof.